Skip to content

The Utility of Treatment With Nasogastric Tube Placement for Small Bowel Obstruction

The Utility of Treatment With Nasogastric Tube Placement for Small Bowel Obstruction in Adult Patients in the Emergency Department; an Observational Multicenter Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06262815
Acronym
NGTUBE-OBS
Enrollment
400
Registered
2024-02-16
Start date
2024-01-01
Completion date
2024-12-31
Last updated
2024-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Small Bowel Obstruction, Frailty, Nasogastric Tube

Keywords

Small bowel obstruction, nasogastric tube, pain, mortality, morbidity, frailty

Brief summary

Small bowel obstruction (SBO) occurs when the normal movements of the small bowel is obstructed, most commonly due to adhesion related to previous abdominal surgery. This may cause strangulation of the small bowel with reduced blood flow which is a surgical emergency requiring prompt treatment in the operating room. If there are no signs of strangulation or ischemia of the bowel at the time of diagnosis, international guidelines recommend initial treatment with intravenous fluids and nasogastric tube placement. However, there is emerging debate regarding non-selective treatment with nasogastric tube placement in patients with SBO. This management started around 1930 as a means to reduce pain in patients with SBO, in conjunction with other additions to management, like intravenous fluids. However the effect and utility of routine nasogastric tube placement have not been prospectively evaluated. There are a total of three retrospective observational studies in the past decade with a total of 759 patients where 292 (36%) were managed without a nasogastric tube. There was no difference in the rates of conservative treatment failure (requiring surgery), complications (vomiting, pneumonia) or mortality between patients receiving a nasogastric tube and those who didn't. However, the retrospective design of these studies limits their validity. Furthermore, nasogastric tube placement has been shown to be one of the more painful interventions patients may experience in-hospital. This calls into question the patient benefit of routine nasogastric tube placement in patients with SBO and further studies are needed to discern the utility of this intervention. Definitive treatment for SBO is surgical adhesiolysis but there is debate regarding the timing of surgery, particularly in older adults. A large proportion of patients may be managed conservatively with oral contrast and repeated radiological evaluation and the obstruction will resolve in many patients within 24 to 48 hours. This timeframe is dependent on factors related to the disease itself as well as patient related factors like previous surgery and comorbidities. Older patients are at high risk for complications but current available data is insufficient to inform practice in this population. Frailty, a state of increased vulnerability and susceptibility to adverse events, has been shown to be an independent prognosticator in older adults in the Emergency Department(ED) and suggested as a potential measure to risk stratify older adults with SBO. However to the authors knowledge there is no available data on frailty in older adults with SBO and only one prospective observational trial looking at older adults with SBO. Despite SBO being one of the most common surgical emergencies in older adults. To investigate the potential benefit of nasogastric tube placement in patients with SBO and the ability of frailty to prognosticate outcomes in older adults better evidence is needed.

Interventions

Conventional nasogastric tube placement done for decompression of small bowel obstruction

DIAGNOSTIC_TESTClinical Frailty Scale

The scale described by Rockwood et al. categorizing patients >65 years of age on a 9 item scale depending on the frailty.

Sponsors

Linkoeping University
CollaboratorOTHER_GOV
Daniel Wilhelms
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Diagnosed small bowel obstruction * Age 18 or older

Exclusion criteria

* Abdominal surgery within 7 days * Not able to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Pain at Emergency Department dischargeat Emergency Department Discharge, assessed up to 48 hoursself-reported Pain on a Numeric Rating Scale from 0 to 10 were higher is worse

Secondary

MeasureTime frameDescription
Hospital Length of StayUp to 90 days from inclusionDuration of days spent in the hospital by patients with Small Bowel obstruction admitted from the Emergency Department
Mortalityup to 90 days from inclusionMortality of any cause
Nausea at Emergency Department dischargeat Emergency Department discharge, assessed up to 48 hoursNausea as self-reported by patients on a numeric rating scale from 0 to 10 were higher is worse
Emergency Surgeryup to 30 days from inclusionAny emergency operation
Emergency Department Length of Stayup to 7 days from inclusionLength of stay, defined as the time from registration in the Emergency Department to discharge from the Emergency Department at the visit of inclusion.
Admission for Small bowel obstructionup to 365 days from inclusion in the studyAny admission to a hospital in Sweden with a primary discharge diagnosis of small bowel obstruction

Countries

Sweden

Contacts

Primary ContactJens Wretborn, PhD
jens.wretborn@liu.se+4610 103 00 00

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026